Hjem › Mavekreft › New York

Kliniske studier for Mavekreft i New York

38 studier for Mavekreft søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Montefiore Medical Center-Einstein Campus, The Bronx
James J Peters VA Medical Center, The Bronx

RekruttererFrivillige helsepersonell ønskes velkommen

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site, Commack

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06219941

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Memorial Sloan Kettering Cancer Center, New York
Local Institution - 0274, Rochester

RekruttererFase 2/3

Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07700979

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Memorial Sloan Kettering Cancer Center Pharmacy (IMP ship to address), Long Island City
Memorial Sloan Kettering Cancer Center Pharmacy (IMP storage location), Long Island City
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
og 2 flere

RekruttererFase 2/3

Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07392892

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site, New York

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07069712

A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
og 1 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07631000

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Commack

RekruttererFase 2

Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Roswell Park Comprehensive Cancer Center, Buffalo

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05274048

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07217704

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
og 1 flere

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07818018

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, New York
Research Site, New York
Research Site, New York
og 2 flere

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Icahn School of Medicine at Mount Sinai, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Memorial Sloan Kettering Hospital, New York

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07070232

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07227168

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Northwell Health Cancer Institute at Huntington, Greenlawn

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT04329494

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Memorial Sloan Kettering Cancer Center - MAIN, New York
Montefiore Medical Center, The Bronx

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06731478

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Cayuga Medical Center, Ithaca
Mt. Sinai, New York
Memorial Sloan Kettering Cancer Center, New York
og 1 flere

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT03526835

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

START New York, Lake Success
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT06657144

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Memorial Sloan Kettering Cancer Center, New York

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT06695845

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
og 7 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04389632